Trial Profile
Impact of Denosumab in the Prevention of Bone Loss in Non-menopausal Women With Anorexia Nervosa
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Denosumab (Primary)
- Indications Anorexia nervosa
- Focus Therapeutic Use
- Acronyms DIBLAN
- 03 Jan 2019 Status changed from recruiting to discontinued.
- 18 Nov 2016 Status changed from not yet recruiting to recruiting.
- 19 Apr 2016 Planned initiation date changed from 1 Dec 2015 to 1 May 2016.